TOELY looking comfortable at new ATH
Updated
TOELY has performed on-par with the rest of the sector throughout the Covid era, despite its OTC status and comparative obscurity for ordinary traders (70B mkt cap vs ASML, AMAT etc). Another new ATH reached just before earnings, and a rosy outlook ahead. Rising support levels still accelerating, price action above all meaningful MAs. On track for more gains towards the 135-145 target.
Note
Retested the "new support" on 04-05 May, and it has unsurprisingly held.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.